☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Insights+: The US FDA New Drug Approvals in January 2022
February 17, 2022
BMS Reports Results of Mavacamten in P-III (VALOR-HCM) Study for the Treatment of Obstructive Hypertrophic Cardiomyopathy
February 17, 2022
BeiGene’s Brukinsa (zanubrutinib) Receives Swissmedic Approval for the Treatment of Adult Patients with Waldenström’s Macroglobuli...
February 17, 2022
Pfizer and OPKO’s Ngenla (somatrogon) Receives EC’s Marketing Authorization for the Treatment of Pediatric Growth Hormone Deficien...
February 17, 2022
LEXEO Receives the US FDA’s IND Clearance of LX2006 for the Treatment of Friedreich’s Ataxia Cardiomyopathy
February 17, 2022
Gilead Reports One-Year Results of Lenacapavir in P-II/III (CAPELLA) & P-II (CALIBRATE) Trial for the Treatment of HIV
February 17, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions